COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences Inc. Commences Production of its Pomegranate Flavored Version of Tauri-Gum
17/09/2019
Tauri-Gum™ Product Line – Now Encompasses Three Dynamic Flavors! New York, NY, Sept. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue [...]
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th
17/09/2019
DUBLIN, Ireland, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, a once-nightly formulation of sodium oxybate, for narcolepsy, today announced that [...]
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease
17/09/2019
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease Follows Breakthrough Device designation for Virtue Sirolimus-Eluting Balloon [...]
Biogen Ranked #1 Biotechnology Company on Dow Jones Sustainability World Index
17/09/2019
CAMBRIDGE, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that it has been ranked the #1 biotechnology company on the Dow Jones Sustainability World Index (DJSI World) for the [...]
Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss
17/09/2019
Results expected in second half of 2020 SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, [...]
Medtronic Introduces Envision™ Pro Continuous Glucose Monitoring (CGM) System in Europe
17/09/2019
Next-Generation Professional CGM Combines Valuable Data with Optimal User Experience DUBLIN, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, [...]
Demant A/S: Update on IT infrastructure incident
17/09/2019
Company announcement no 2019-10 17 September 2019 As previously announced, the Demant Group experienced a critical incident in our internal IT infrastructure on 3 September 2019 when the Group’s IT infrastructure was [...]
CMR Surgical raises £195 million ($240 million) in Series C financing
17/09/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical raises £195 million ($240 million) in Series C financing ~ Europe’s largest private financing round in the medical technology sector ~ Financing will [...]
Nicox: First Half 2019 Financial Results and Business Update
17/09/2019
Press Release Nicox: First Half 2019 Financial Results and Business Update H1 2019 net revenue 1 of €5.6 million and net loss 2 of €0.8 million Enrollment completed in NCX 470 Phase 2 DOLOMITES clinical trial in [...]
Nicox : Résultats financiers du premier semestre 2019 et point des activités
17/09/2019
Communiqué de presse Nicox : Résultats financiers du premier semestre 2019 et point des activités Chiffre d’affaires net 1 pour le premier semestre 2019 de 5,6 millions d’euros et perte nette 2 de 0,8 million d’euros [...]
Novartis Cosentyx® positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
17/09/2019
Phase III PREVENT study met 16-week primary endpoint of ASAS40 in patients with active non-radiographic axial spondyloarthritis (nr-axSpA). All secondary endpoints were also met [1] Novartis has submitted to EMA for [...]
Santhera to Present Long-Term Data with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy at Upcoming Medical Congresses
17/09/2019
Pratteln, Switzerland, September 17, 2019 – Santhera Pharmaceuticals (SIX: SANN) will present data on the therapeutic effects of long-term treatment with Puldysa® (idebenone) in Duchenne muscular dystrophy (DMD) at the [...]
Medtronic Announces Robotic-Assisted Surgery Investor Update
17/09/2019
DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will host aRobotic-Assisted Surgery (RAS) Investor Update on Tuesday, September 24, [...]
HMS Acquires VitreosHealth
17/09/2019
Pioneer in Advanced Analytics for Predictive and Prescriptive Health Insights to Enhance Company’s Award-Winning Population Health Management Solution Suite IRVING, Texas, Sept. 16, 2019 (GLOBE NEWSWIRE) -- HMS Holdings [...]
Axiom Real-Time Metrics Celebrates Grand Opening of its New Headquarters in Toronto and Reflects on 18 Years of Growth and Achievement
16/09/2019
TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is marking the opening of its new global corporate headquarters with a [...]
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Launches Branded Product Line, Introducing Eight Products for the Recreational Market, and Begins Shipping to Ontario Cannabis Store
16/09/2019
VANCOUVER, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis [...]
Stereotaxis Announces CFO Transition
16/09/2019
ST. LOUIS, Mo., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE American: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Kimberly Peery [...]
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
16/09/2019
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
16/09/2019
Highly statistically significant results at the primary endpoint - statistical significance seen as early as Day 29 Highly statistically significant results on all secondary efficacy endpoints WART-302 is the first of [...]

Pages